论文部分内容阅读
目的:探讨硝苯地平缓释片治疗高血压合并糖尿病的临床治疗效果。方法:选取2012年9月-2014年9月增城市小楼镇卫生院80例高血压合并糖尿病患者,将其随机分为观察组和对照组,每组40例,两组均给予常规治疗,对照组给予厄贝沙坦进行治疗,观察组给予硝苯地平缓释片进行治疗,观察、比较两组患者的临床疗效。结果:观察组患者的治疗总有效率为95%,而对照组的治疗总有效率为80%,两组比较,差异具有统计学意义(P<0.05)。观察组治疗后的各项指标均明显优于治疗前和对照组,差异具有统计学意义(P<0.05)。结论:在治疗高血压合并糖尿病时,使用硝苯地平缓释剂能有效提高临床疗效,具有显著的降压效果,且不影响糖脂代谢,使用安全性较高。
Objective: To investigate the clinical effect of nifedipine sustained-release tablets in the treatment of hypertension complicated with diabetes. Methods: From September 2012 to September 2014, 80 patients with hypertension and diabetes mellitus in Xiaolongzhen Hospital of Zengcheng were randomly divided into observation group and control group, 40 cases in each group. Both groups were given routine treatment, The control group was treated with irbesartan. The observation group was given nifedipine sustained-release tablets for treatment. The clinical efficacy of the two groups were compared. Results: The total effective rate of observation group was 95%, while that of control group was 80%. There was significant difference between the two groups (P <0.05). The observation group after treatment, the indicators were significantly better than before treatment and control group, the difference was statistically significant (P <0.05). Conclusion: In the treatment of hypertension with diabetes, the use of nifedipine sustained-release agents can effectively improve the clinical efficacy, with significant antihypertensive effect, and does not affect the metabolism of glucose and lipid, the use of high safety.